- FGEN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3ASR Filing
FibroGen (FGEN) S-3ASRAutomatic shelf registration
Filed: 1 Mar 17, 12:00am
EXHIBIT 12.1
STATEMENT OF COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES AND
TO COMBINED FIXED CHARGES AND PREFERENCE DIVIDENDS
For the Year Ended December 31, | ||||||||||||||||||||
2012 | 2013 | 2014 | 2015 | 2016 | ||||||||||||||||
(in thousands) | ||||||||||||||||||||
Earnings: | ||||||||||||||||||||
Income (loss) from continuing operations before income taxes | $ | (32,671 | ) | $ | (14,943 | ) | $ | (59,504 | ) | $ | (85,537 | ) | $ | (61,751 | ) | |||||
Fixed charges | 10,026 | 10,702 | 11,108 | 11,033 | 10,725 | |||||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Earnings (Loss) as Defined | $ | (22,645 | ) | $ | (4,241 | ) | $ | (48,396 | ) | $ | (74,504 | ) | $ | (51,026 | ) | |||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Fixed Charges: | ||||||||||||||||||||
Interest expense | $ | 10,026 | $ | 10,702 | $ | 11,108 | $ | 11,033 | $ | 10,725 | ||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Total Fixed Charges | $ | 10,026 | $ | 10,702 | $ | 11,108 | $ | 11,033 | $ | 10,725 | ||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Preferred Stock Dividends | $ | — | $ | — | $ | — | $ | — | $ | — | ||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Ratio of Earnings (Loss) to Fixed Charges | Note 1 | Note 1 | Note 1 | Note 1 | Note 1 | |||||||||||||||
Ratio of Earnings (Loss) to Combined Fixed Charges and Preferred Dividends | Note 2 | Note 2 | Note 2 | Note 2 | Note 2 |
Note 1: For the fiscal years ended December 31, 2012, 2013, 2014, 2015 and 2016, our earnings were insufficient to cover fixed charges by ($32.7) million, ($14.9) million, ($59.5) million, ($85.5) million, and ($61.7) million, respectively.
Note 2: For the fiscal years ended December 31, 2012, 2013, 2014, 2015 and 2016, our combined fixed charges and preference dividends exceeded earnings by ($32.7) million, ($14.9) million, ($59.5) million, ($85.5) million, and ($61.7) million, respectively.